Mirae Asset Global Investments Co., Ltd. Innoviva, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,086 shares of INVA stock, worth $38,215. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,086
Previous 2,263
7.82%
Holding current value
$38,215
Previous $43,000
16.28%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INVA
# of Institutions
227Shares Held
79.1MCall Options Held
37.6KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$176 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$133 Million34.93% of portfolio
-
Franklin Resources Inc San Mateo, CA6.75MShares$124 Million0.04% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$115 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.23MShares$114 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.28B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...